NYSE$MO
Altria Group Inc · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
Altria's fourth-quarter earnings were impacted by a significant impairment charge related to its investment in JUUL, but its core tobacco businesses demonstrated strong performance.
Altria reported a net loss due to a $4.1 billion impairment charge on its JUUL investment, though its core tobacco businesses performed well. The company exceeded its cost savings target and increased its dividend. Altria is revising its terms of investment in JUUL and focusing on pre-market tobacco product applications.
- Altria's core tobacco businesses delivered outstanding performance in 2019.
- Altria exceeded its $575 million annualized cost savings target.
- Altria increased the dividend for the 54th time in 50 years
- Altria recorded a fourth-quarter, non-cash pre-tax impairment charge of $4.1 billion related to its investment in JUUL.
Headline financials
Revenue & EPS history
Altria · Revenue · Quarterly
$4.8B
Revenue by segment
Altria · $5.76B total across 2 segments · Q4 2019
- Smokeable Products$5.16B-2.7%89.5%
- Oral Tobacco Products$605M+5.8%10.5%
Forward guidance
Altria expects its 2020 full-year adjusted diluted EPS to be in a range of $4.39 to $4.51, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.22 in 2019.
Tailwinds
- Increased investments related to PM USA’s commercialization efforts for IQOS
- Helix’s plans to manufacture and expand U.S. distribution of on!
- One extra shipping day in the first quarter.
- Altria expects its 2020 full-year adjusted diluted EPS to be in a range of $4.39 to $4.51
- Altria expects its 2020 full-year adjusted effective tax rate will be in a range of 23.5% to 24.5%
Headwinds
- Estimated per share charges in 2020 of $0.05 of tax expense resulting from the Tax Cuts and Jobs Act (Tax Reform Act) related to a tax basis adjustment to Altria’s ABI investment
- Altria expects the 2020 full-year total domestic cigarette industry adjusted volume decline rate to be in a range of 4% to 6%, which includes the impact of federal legislation raising the minimum age to purchase all tobacco products to 21.
- Altria expects continued volatility across tobacco categories and will no longer provide a multi-year forecast for U.S. cigarette volume declines.
- unfavorable litigation outcomes
- government, including U.S. Food and Drug Administration (FDA), and private sector actions that impact adult tobacco consumer acceptability of, or access to, tobacco products
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2019
-0.3%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+0.7%
Avg return
30 days after
47%
34 / 72 earnings
Positive
+6.7%
Q3 2024
Best reaction
-8.2%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +6.7% | +2.1% | |
| Q4 2025 | -5.2% | +1.6% | +9.4% | |
| Q3 2025 | -7.8% | -7.5% | -4.8% | |
| Q2 2025 | +3.6% | +4.3% | +13.2% | |
| Q1 2025 | +1.0% | +2.4% | +2.2% | |
| Q4 2024 | -2.1% | -0.1% | +6.1% | |
| Q3 2024 | +6.7% | +7.3% | +14.3% | |
| Q2 2024 | -1.0% | -2.4% | +6.4% | |
| Q1 2024 | +1.1% | +2.1% | +6.0% | |
| Q4 2023 | +3.1% | +1.2% | +1.8% | |
| Q3 2023 | -8.2% | -6.2% | -3.2% | |
| Q2 2023 | -1.9% | -3.1% | -2.6% | |
| Q1 2023 | +1.8% | +1.0% | -4.5% | |
| Q4 2022 | +4.3% | +4.3% | +3.3% | |
| Q3 2022 | +0.0% | -0.4% | -3.4% | |
| Q2 2022 | -0.5% | -0.5% | +4.1% | |
| Q1 2022 | +1.2% | +0.9% | -0.9% | |
| Q4 2021 | +2.0% | +2.4% | +4.1% | |
| Q3 2021 | -7.1% | -7.1% | -7.9% | |
| Q2 2021 | +0.9% | +0.4% | +4.0% | |
| Q1 2021 | +1.2% | +1.4% | +4.3% | |
| Q4 2020 | -1.8% | -0.6% | +4.3% | |
| Q3 2020 | -1.1% | +3.3% | +9.5% | |
| Q2 2020 | -1.2% | -2.3% | +3.8% | |
| Q1 2020 | -6.3% | -9.1% | -3.5% | |
| Q4 2019 | -5.1% | -7.2% | -19.4% | |
| Q3 2019 | -2.0% | +0.6% | +8.1% | |
| Q2 2019 | -6.4% | -4.7% | -12.0% | |
| Q1 2019 | -3.5% | -0.7% | -4.2% | |
| Q4 2018 | +2.9% | +2.6% | +10.4% | |
| Q3 2018 | +1.3% | +5.7% | -13.8% | |
| Q2 2018 | +0.1% | +1.4% | +1.6% | |
| Q1 2018 | +0.5% | +0.3% | -0.4% | |
| Q4 2017 | -1.3% | -5.4% | -11.1% | |
| Q3 2017 | +1.8% | +0.7% | +2.6% | |
| Q2 2017 | -6.7% | -8.7% | -10.7% | |
| Q1 2017 | -0.8% | +0.2% | +6.5% | |
| Q4 2016 | +0.4% | +0.2% | +6.2% | |
| Q3 2016 | +2.1% | +1.5% | -0.1% | |
| Q2 2016 | -1.2% | -0.4% | -3.1% | |
| Q1 2016 | +1.9% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -1.6% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -0.1% | — | — | |
| Q4 2014 | -1.1% | — | — | |
| Q3 2014 | +1.6% | — | — | |
| Q1 2014 | +2.1% | — | — | |
| Q4 2013 | -3.3% | — | — | |
| Q3 2013 | -0.4% | — | — | |
| Q2 2013 | -3.6% | — | — | |
| Q1 2013 | +1.5% | — | — | |
| Q4 2012 | +1.5% | — | — | |
| Q3 2012 | -1.2% | — | — | |
| Q2 2012 | -0.3% | — | — | |
| Q1 2012 | -0.2% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | +0.7% | — | — | |
| Q1 2011 | -0.5% | — | — | |
| Q4 2007 | +2.7% | — | — | |
| Q4 2010 | +2.7% | — | — | |
| Q3 2010 | +1.2% | — | — | |
| Q2 2010 | -1.4% | — | — | |
| Q1 2009 | +1.2% | — | — | |
| Q1 2010 | +0.9% | — | — | |
| Q4 2009 | +2.2% | — | — | |
| Q3 2008 | -0.5% | — | — | |
| Q3 2009 | -0.5% | — | — | |
| Q4 2008 | -0.7% | — | — | |
| Q2 2009 | -0.7% | — | — | |
| Q2 2008 | -0.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro